Case File №
#VI-2026-0646
Yongkang Nuoao Trading Co
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
43 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | B Good | 8 | 7.2 | 5.8 | 9.0 | 25 Jul 2025 |
| Tirzepatide | X Unrated | 1 | 5.9 | 5.9 | 5.9 | 11 Jun 2025 |
| 5-amino-1MQ | X N/A | 1 | 5.6 | 5.6 | 5.6 | 2 Apr 2025 |
| ACE-031 | X N/A | 1 | 4.1 | 4.1 | 4.1 | 9 Jun 2025 |
| AHK-CU | X N/A | 1 | 8.3 | 8.3 | 8.3 | 24 Apr 2025 |
| Alprostadil | X N/A | 1 | 5.7 | 5.7 | 5.7 | 8 Jul 2025 |
| Anavar (Oxandrolone) Raw | X N/A | 1 | 4.0 | 3.9 | 3.9 | 28 Mar 2025 |
| ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 | X N/A | 1 | 6.9 | 6.9 | 6.9 | 13 Jun 2025 |
| BAM15 | X N/A | 1 | 8.2 | 8.2 | 8.2 | 17 Dec 2024 |
| Blend 300 (TRA/Mast P/Test P) | X N/A | 1 | 7.5 | 7.5 | 7.5 | 13 Feb 2025 |
| BMK ethyl glycidate CAS 41232-97-7 | X N/A | 1 | 6.5 | 6.5 | 6.5 | 2 Apr 2025 |
| BMK methyl glycidate CAS 80532-66-7 | X N/A | 1 | 7.1 | 7.1 | 7.1 | 9 Jun 2025 |
| Botulinum toxin | X N/A | 1 | 6.7 | 6.7 | 6.7 | 8 Jul 2025 |
| Cerebrolysin | X N/A | 1 | 5.2 | 5.2 | 5.2 | 9 Jun 2025 |
| CJC-1295 With DAC | X N/A | 1 | 9.2 | 9.2 | 9.2 | 8 Jul 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 7.9 | 7.9 | 7.9 | 13 Jun 2025 |
| Clenbuterol | X N/A | 1 | 9.4 | 9.4 | 9.4 | 17 Dec 2024 |
| DHB (1-Test Cyp) | X N/A | 1 | 8.2 | 8.2 | 8.2 | 13 Jun 2025 |
| Dihexa | X N/A | 1 | 5.8 | 5.8 | 5.8 | 2 Apr 2025 |
| Drostanolone Propionate (Mast P) Raw | X N/A | 1 | 6.1 | 6.1 | 6.1 | 21 May 2025 |
| EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 | X N/A | 1 | 5.3 | 5.3 | 5.3 | 9 Jun 2025 |
| Enclomiphene | X N/A | 1 | 6.1 | 6.1 | 6.1 | 27 Feb 2025 |
| Glutathione | X N/A | 1 | 5.3 | 5.3 | 5.3 | 3 Jun 2025 |
| Ivermectin | X N/A | 1 | 6.0 | 6.0 | 6.0 | 3 Jul 2025 |
| Lipo-C FOCUS 425mg | X N/A | 1 | 6.6 | 6.6 | 6.6 | 25 Apr 2025 |
| Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | X N/A | 1 | 7.5 | 7.5 | 7.5 | 11 Jun 2025 |
| MENT (Trestolone Acetate) | X N/A | 1 | 5.0 | 5.0 | 5.0 | 14 Jan 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 5.8 | 5.8 | 5.8 | 7 May 2025 |
| Orforglipron | X N/A | 1 | 8.0 | 8.0 | 8.0 | 21 May 2025 |
| Oxytocin Acetate | X N/A | 1 | 6.8 | 6.8 | 6.8 | 13 Feb 2025 |
| Pancragen | X N/A | 1 | 8.2 | 8.2 | 8.2 | 8 Jul 2025 |
| PNC 27 | X N/A | 1 | 5.6 | 5.6 | 5.6 | 3 Jul 2025 |
| Prostamax | X N/A | 1 | 6.1 | 6.1 | 6.1 | 13 Jun 2025 |
| PTD-DBM | X N/A | 1 | 4.8 | 4.8 | 4.8 | 16 Mar 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 8.5 | 8.5 | 8.5 | 16 Mar 2025 |
| SLU-PP-332 250mcg + BAM15 50mcg Blend | X N/A | 1 | 6.4 | 6.4 | 6.4 | 6 May 2025 |
| Tamoxifen (Nolvadex) Raw | X N/A | 1 | 7.4 | 7.4 | 7.4 | 2 Apr 2025 |
| Test Enanthate | X N/A | 1 | 8.3 | 8.3 | 8.3 | 11 Jun 2025 |
| Thymosin Alpha-1 | X N/A | 1 | 6.2 | 6.2 | 6.2 | 28 Mar 2025 |
| Tren Hex Raw | X N/A | 1 | 7.9 | 7.9 | 7.9 | 2 Apr 2025 |
| Trestolone Acetate (MENT) Raw | X N/A | 1 | 8.4 | 8.4 | 8.4 | 7 May 2025 |
| Vilon | X N/A | 1 | 4.0 | 4.0 | 4.0 | 6 May 2025 |
| Vitamin B12 1mg/ml | X N/A | 1 | 7.7 | 7.7 | 7.7 | 21 May 2025 |
Exhibit II
Evidence Log
48 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | Thymosin Alpha-1 | 8.4 A | 20mg | 17.6mg | -12.2% | 99.39% | vaohj9 | Lab F | Public |
| 24 May 2026 | Retatrutide | 5.9 C | 10mg | 9.98mg | -0.2% | 98.86% | (no batch ID) | Lab E | Public |
| 24 May 2026 | Clenbuterol | 8.8 A | 100mg | 104.9mg | +4.9% | 95.93% | 28t3tx | Lab D | Community |
| 24 May 2026 | SLU-PP-332 250mcg + BAM15 50mcg Blend | 4.5 C | 10mg | 9.9mg | -1.5% | 98.05% | qn6gx4 | Lab G | Community |
| 24 May 2026 | Dihexa | 6.3 A | 10mg | 10.5mg | +5.2% | 99.53% | fwyuok | Lab C | Public |
| 24 May 2026 | Ivermectin | 6.8 A | 100mg | 115.1mg | +15.1% | 95.75% | uof359 | Lab E | Community |
| 24 May 2026 | Prostamax | 5.9 B | 30mg | 34.8mg | +16.1% | 97.50% | 1441f5 | Lab A | Public |
| 23 May 2026 | BMK ethyl glycidate CAS 41232-97-7 | 8.0 A | 10g | 10.1g | +1.1% | 99.77% | t6w27v | Lab E | Public |
| 23 May 2026 | ACE-031 | 5.3 B | 50mg | 50.4mg | +0.7% | 96.44% | shnhgi | Lab A | Public |
| 23 May 2026 | ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 | 6.5 A | 10g | 9.7g | -2.6% | 97.38% | 7f6ad8 | Lab E | Public |
| 21 May 2026 | Retatrutide | 5.8 C | 50mg | 56mg | +12.0% | 99.80% | (no batch ID) | Lab G | Public |
| 21 May 2026 | Retatrutide | 5.8 C | 20mg | 33.7mg | +68.5% | 99.68% | 12/5/2025 | Lab E | Public |
| 21 May 2026 | Cerebrolysin | 5.2 B | 30mg | 26.9mg | -10.4% | 95.66% | 0w2ocz | Lab D | Community |
| 21 May 2026 | Drostanolone Propionate (Mast P) Raw | 6.3 A | 500g | 606.4g | +21.3% | 96.23% | n9ovj6 | Lab E | Community |
| 21 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.2 A | 30mg | 33.2mg | +10.8% | 97.76% | xc00sr | Lab A | Community |
| 20 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 8.5 A | 15mg | 15.1mg | +0.7% | 96.70% | 1s3jof | Lab B | Community |
| 19 May 2026 | BAM15 | 8.3 A | 20mg | 20.6mg | +3.2% | 98.34% | tw7d06 | Lab C | Community |
| 17 May 2026 | Lipo-C FOCUS 425mg | 6.1 A | 300mg/ml | 272.4mg/ml | -9.2% | 97.72% | 9p7gls | Lab B | Public |
| 29 Jan 2026 | Anavar (Oxandrolone) Raw | 5.9 B | 500g | 490.7g | -1.9% | 98.04% | 3bgqhh | Lab D | Community |
| 29 Jan 2026 | CJC-1295 With DAC | 7.8 A | 20mg | 17.9mg | -10.4% | 99.65% | vop6z4 | Lab A | Public |
| 29 Jan 2026 | Vilon | 4.0 C | 5mg | 5.0mg | -0.0% | 97.81% | rd7sa0 | Lab E | Public |
| 19 Jan 2026 | Enclomiphene | 5.1 B | 50mg | 56.6mg | +13.1% | 95.64% | ox0aqx | Lab F | Public |
| 19 Jan 2026 | MENT (Trestolone Acetate) | 4.6 C | 100mg/ml | 101.3mg/ml | +1.3% | 98.17% | 4w1skx | Lab G | Community |
| 19 Jan 2026 | Orforglipron | 9.6 A | 25mg | 28.5mg | +14.1% | 95.08% | 4s5jm5 | Lab A | Community |
| 9 Jan 2026 | AHK-CU | 8.3 A | 2mg | 1.9mg | -3.9% | 95.52% | ao9972 | Lab A | Community |
| 9 Jan 2026 | Blend 300 (TRA/Mast P/Test P) | 5.4 B | 200mg/ml | 177.3mg/ml | -11.3% | 96.19% | kjncgt | Lab F | Public |
| 9 Jan 2026 | Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | 6.2 A | 100mg/ml | 103.3mg/ml | +3.3% | 99.50% | 6c8mll | Lab G | Public |
| 9 Jan 2026 | Test Enanthate | 10.0 A | 200mg/ml | 187.3mg/ml | -6.4% | 99.22% | n48wh0 | Lab A | Public |
| 9 Jan 2026 | Vitamin B12 1mg/ml | 7.7 A | 300mg/ml | 316.9mg/ml | +5.6% | 95.84% | 4iulkm | Lab D | Community |
| 7 Jan 2026 | Retatrutide | 7.5 A | 5mg | 4.9mg | -2.0% | 99.70% | (no batch ID) | Lab G | Public |
| 6 Jan 2026 | Alprostadil | 8.7 A | 5mg | 4.9mg | -2.3% | 96.94% | 8wzc5s | Lab C | Public |
| 6 Jan 2026 | Oxytocin Acetate | 6.2 A | 10mg | 12.1mg | +20.5% | 96.38% | 4gkz9l | Lab E | Community |
| 6 Jan 2026 | Tamoxifen (Nolvadex) Raw | 8.4 A | 500g | 519.3g | +3.9% | 97.95% | jp8yp4 | Lab B | Community |
| 29 Dec 2025 | Retatrutide | 7.8 A | 15mg | 15.6mg | +4.0% | 99.80% | (no batch ID) | Lab G | Public |
| 29 Dec 2025 | Trestolone Acetate (MENT) Raw | 8.0 A | 5g | 5.6g | +11.4% | 95.19% | i0uwht | Lab D | Community |
| 5 Dec 2025 | Tren Hex Raw | 8.7 A | 1g | 1.0g | -2.2% | 99.69% | zfev7y | Lab C | Public |
| 23 Nov 2025 | Selank 10mg + Semax 10mg Blend | 6.5 A | 2mg | 2.4mg | +17.6% | 97.02% | iidlru | Lab D | Public |
| 17 Nov 2025 | 5-amino-1MQ | 5.7 B | 10mg | 11.0mg | +9.7% | 97.46% | uzwbeq | Lab C | Public |
| 17 Nov 2025 | DHB (1-Test Cyp) | 7.8 A | 100mg/ml | 116.0mg/ml | +16.0% | 95.49% | rfks1s | Lab B | Public |
| 17 Nov 2025 | Glutathione | 6.8 A | 30mg | 29.7mg | -1.1% | 99.37% | 7da7bv | Lab F | Community |
| 17 Nov 2025 | Pancragen | 9.6 A | 30mg | 29.3mg | -2.3% | 96.21% | 7wr3cm | Lab F | Public |
| 17 Nov 2025 | PNC 27 | 7.1 A | 5mg | 5.6mg | +11.3% | 96.79% | bn1l2u | Lab C | Community |
| 4 Nov 2025 | EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 | 4.3 C | 1g | 1.1g | +13.6% | 97.74% | wmed0h | Lab A | Public |
| 29 Oct 2025 | Retatrutide | 8.0 A | 15mg | 14.3mg | -4.7% | 99.95% | (no batch ID) | Lab E | Public |
| 17 Oct 2025 | PTD-DBM | 4.0 C | 2mg | 1.9mg | -6.5% | 98.21% | hjedms | Lab A | Public |
| 9 Oct 2025 | BMK methyl glycidate CAS 80532-66-7 | 9.5 A | 5g | 4.8g | -4.6% | 96.26% | sqe1w3 | Lab F | Public |
| 9 Oct 2025 | Botulinum toxin | 6.8 A | 5mg | 5.5mg | +10.1% | 96.40% | bmvuey | Lab B | Community |
| 21 Aug 2025 | Retatrutide | 8.0 A | 15mg | 14.5mg | -3.3% | 99.91% | (no batch ID) | Lab E | Public |
— END OF EVIDENCE LOG —